Bolder BioPATH - Ownership and Business Overview

Life ScienceCompany

Bolder BioPATH Ownership

Who owns Bolder BioPATH?

Bolder BioPATH is owned by Inotiv. It was acquired on April 16, 2021.

Bolder BioPATH Business Overview

Where is Bolder BioPATH headquartered?

Bolder BioPATH is headquartered in Boulder, Colorado.

What sector is Bolder BioPATH in?

Bolder BioPATH is a life science company.

When was Bolder BioPATH founded?

Bolder BioPATH was founded in 2003.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 391 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 345 by strategics.

Bolder BioPATH

Bolder BioPATH, Inc.

5541 Central Ave, Suite 160,
Boulder, Colorado 80301
United States,
www.bolderbiopath.com

Bolder BioPATH is a contract pharmacology and pathology company specializing in vivo models of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diseases of the central nervous system, and other autoimmune, inflammation, and pain models. Bolder BioPATH was founded in 2003 and is based in Boulder, Colorado.


 Subscribe to unlock this and 206,305
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.